ABBOTT LABORATORIES — Director's Dealing 2007

Aug 28, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-08-27

Reporting Person: Tyree James L (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-08-27	Common shares without par value	M	11061	$41.95	Acquired	117020	Direct
2007-08-27	Common shares without par value	F	9712	$52.53	Disposed	107308	Direct
2007-08-27	Common shares without par value	A	5400	$52.14	Acquired	112708	Direct
2007-08-27	Common shares without par value	A	4000	$52.14	Acquired	116708	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-08-27	Option (right to buy)	$41.95	M	11061	Disposed	2013-02-13	common shares (11061)	Direct
2007-08-27	Option (right to buy)	$52.53	A	9712	Acquired	2013-02-13	common shares (9712)	Direct
2007-08-27	Option (right to buy)	$52.14	A	22000	Acquired	2017-08-27	common shares (22000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1155	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

F3: Balance in the Abbott Laboratories Stock Retirement Trust as of August 24, 2007.

F4: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

F5: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in increments of 7,334 on 08/27/2008, 7,333 on 08/27/2009, and 7,333 on 08/27/2010.